KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Quest Diagnostics (DGX) Cost of Revenue (2016 - 2025)

Historic Cost of Revenue for Quest Diagnostics (DGX) over the last 17 years, with Q3 2025 value amounting to $1.9 billion.

  • Quest Diagnostics' Cost of Revenue rose 1132.98% to $1.9 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $7.2 billion, marking a year-over-year increase of 1277.86%. This contributed to the annual value of $6.6 billion for FY2024, which is 692.05% up from last year.
  • Quest Diagnostics' Cost of Revenue amounted to $1.9 billion in Q3 2025, which was up 1132.98% from $1.8 billion recorded in Q2 2025.
  • Over the past 5 years, Quest Diagnostics' Cost of Revenue peaked at $1.9 billion during Q3 2025, and registered a low of $1.5 billion during Q3 2023.
  • For the 5-year period, Quest Diagnostics' Cost of Revenue averaged around $1.6 billion, with its median value being $1.6 billion (2022).
  • Its Cost of Revenue has fluctuated over the past 5 years, first skyrocketed by 2817.36% in 2021, then plummeted by 832.36% in 2022.
  • Quarter analysis of 5 years shows Quest Diagnostics' Cost of Revenue stood at $1.7 billion in 2021, then fell by 8.32% to $1.6 billion in 2022, then fell by 1.46% to $1.6 billion in 2023, then grew by 13.6% to $1.8 billion in 2024, then grew by 5.9% to $1.9 billion in 2025.
  • Its last three reported values are $1.9 billion in Q3 2025, $1.8 billion for Q2 2025, and $1.8 billion during Q1 2025.